NOS3 and cardiac hypertrophy: In particular, it has been demonstrated, in High-Fat Diet–Induced Obese Mice, that EMPA improved myocardial hypertrophy/fibrosis and cardiac function and reduced cardiac fat accumulation and mitochondrial injury, augmenting Sestrin2 levels and increasing AMPK and endothelial nitric oxide synthase phosphorylation [39].